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ABSTRACT
Cervical cancer is the second most common cancer among women worldwide and a leading
cause of death in some countries (Jayasekara, 2020). Approximately 13,800 cases of cervical
cancer were diagnosed in the U.S. last year, and about 4,290 women died (American Cancer
Society [ACS], 2020). Regular cervical cancer screening (CCS) reduces morbidity and mortality,
but screening rates are low in the U.S. and at the project site (ACS. 2020). The purpose of this
evidence-based practice (EBP) project was to increase CCS at a Federally Qualified Health
Center (FQHC) with six clinic locations in Northwest Indiana; the primary project site was a clinic
in Porter County. Participants included female patients age 24 to 65 due for CCS (N = 475) who
received an educational email on CCS, including an appointment reminder. Two weeks after the
initial email, patients who had not scheduled an appointment received a second reminder email.
Five weeks after the second email, participants who had not completed CCS received a phone
call. If participants identified Spanish as their preferred language, emails and phone calls were
conducted in Spanish. The emails were also sent to patients at the other five clinics due for
CCS. Data on CCS completed were collected from patient charts every two to four weeks for a
period of five months. The primary outcome examined was CCS uptake at the primary site,
compared with uptake in a comparison group of patients from 2019. Following the interventions,
16.42% of the intervention group completed CCS, while only 11.36% of the comparison group
did so; the increase was statistically significant X2 (1, N = 1109) = 5.96, p < .05. In addition, CCS
completions were collected following each intervention; McNemar’s test was conducted and
found a significant increase in CCS after the second email (X2 = 25.04, df = 1, N = 475, p =
.000) and the phone call intervention (X2 = 36.03, df = 1, N = 475, p = .000). Findings from this
project will be used to recommend continued annual phone call and email interventions at all six
clinics.
Keywords: cervical cancer screening, Papanicolaou smear, uptake, participate, improve,
strategies, interventions
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CHAPTER 1

INTRODUCTION
Background
Cervical cancer is a major cause of death and illness worldwide. It is the second most
common cancer in women worldwide, and in some countries, is a leading cause of death
(Jayasekara, 2020). Cervical cancer occurs when cells lining the cervix start to grow out of
control. Most cervical cancers originate in the transformation zone, where the endocervix, made
of glandular cells, meets the exocervix, which is covered in squamous cells (American Cancer
Society [ACS], 2020). Before cervical cancer develops, the cells in the transformation zone
typically undergo pre-cancerous changes, which are graded one to three according to the
amount of the tissue that appears abnormal. When these pre-cancerous cells are treated early,
nearly all cervical cancers can be prevented or treated successfully (ACS, 2020). However,
most women with early-stage cervical cancer have no symptoms. In the later stages of cervical
cancer, common symptoms include abnormal vaginal bleeding or discharge and pelvic pain
(ACS, 2020). But by the time cervical cancer reaches the advanced stages when symptoms first
appear, successful treatment is less likely and there is a higher risk of mortality (ACS, 2020).
Therefore, regular cervical cancer screening (CCS) is important for early detection and has the
potential to save many lives.
Risk factors for cervical cancer include high-risk human papillomavirus (HPV) infection,
initiation of sexual activity at an early age, multiple sexual partners or one high-risk partner, and
chlamydia infection. In addition, smoking, immunodeficiency, long-term oral contraceptive use,
having three or more full-term pregnancies, history of teenage pregnancy, low socioeconomic
status (SES), and diets low in fruits and vegetables increase a woman’s risk for developing
cervical cancer. Finally, family history of cervical cancer and history of diethylstilbestrol (DES)
use by the patient’s mother during pregnancy are also risk factors (ACS, 2020).
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Appropriate screening at regular intervals is necessary to prevent cervical cancer
morbidity and mortality. The U.S. Preventive Services Task Force (USPSTF, 2018)
recommends that women start CCS at age 21 and receive a Papanicolaou (Pap) test every
three years until age 29. Women ages 30 to 65 have the option of screening with a Pap test
alone every three years, HPV testing alone every five years, or a Pap test plus HPV test (cotesting) every five years (USPSTF, 2018).
Data from the Literature Supporting Need for the Project
Health disparities due to differences in income and race are a problem in the U.S. One
of the Healthy People 2020 goals was to address social determinants of health (SDOH) to
improve the health of all Americans, especially those in underserved populations (Office of
Disease Prevention and Health Promotion [ODPHP], 2020b). Health and Health Care was one
of the areas addressed in the objective, including access to health care, regular primary care,
and improving health literacy (ODPHP, 2020b). This project provided patient education and
CCS reminders at an appropriate reading level, which had the potential to increase health
literacy. The health clinic provides access to care for patients experiencing challenges due to
SDOH.
The literature supports several types of interventions to increase CCS rates, which
promote finding cervical cancer at a pre-cancerous or early stage. In an integrative review of 38
studies, Soares and Silva (2016) reported that education was the intervention most commonly
utilized and successfully improved CCS rates. In addition, case managers or community health
workers, phone calls, letters, postcards, multiple interventions, and community partnerships
were effective to increase CCS uptake (Soares & Silva, 2016). Similarly, Jones et al. (2015)
found that community-based and lay or peer education were effective to improve CCS rates
among underscreened populations. Also, interventions which were targeted to the specific
subgroup or individual were shown to be more effective at increasing rates than more generic
interventions (Jones et al., 2015).
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CCS rates are lower among women of low SES than those of higher SES. Members of
these disadvantaged groups experience many barriers which may make getting screened more
challenging. These include personal barriers, such as cultural beliefs, aversion to clinical
gynecologic exam, and immigration status (Rees et al., 2018). Structural barriers impeding CCS
may include cost, time lost from work to attend appointments, transportation challenges, and
trouble navigating the health system (Rees et al., 2018). In addition, contextual factors can
facilitate or hinder CCS. Plourde et al. (2016) found that lack of provider recommendation
correlated with low CCS rates and that rates were lower among patients of male providers than
those with female providers. Organizational-level factors affecting uptake of breast and CCS
include flexible appointment times, use of reminders, and a focus on quality improvement
(Pluorde et al., 2016).
National Data
According to the ACS (2020), around 13,800 cases of cervical cancer were diagnosed in
the U.S. last year, and approximately 4,290 women died. Healthy People 2020 set objectives to
improve CCS rates and reduce morbidity and mortality from cervical cancer. In 2008, 84.5%; the
Healthy People 2020 goal was for 93% of women in the U.S. between age 21 and 65 to be up to
date for CCS (ODPHP, 2020a). However, only 80.4% of women in the U.S. had received CCS
according to guidelines in 2019 (ACS, 2020). Another objective was to reduce cervical cancer
mortality from 2.4 per 100,000 females to 2.2 deaths per 100,000 females (ODPHP, 2020a).
This project had the potential to help with both goals, increasing CCS rates and reducing
cervical cancer-related mortality.
State Data
In the state of Indiana, an average of 264 women are diagnosed with cervical cancer
every year, and 88 die from it (Indiana State Department of Health [ISDH], 2018). Not only does
cervical cancer exact a toll on lives and health, it also has a great financial cost. In Indiana, the
cost of medical care, including hospital, office visits and medications, for cervical cancer was
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$54,634,601 in 2017 (ISDH, 2018). In addition, disparities by race and SES are a concern with
regards to cervical cancer incidence and mortality. In Indiana, cervical cancer incidence in
African American women was about 18% higher than in White women between 2002 and 2016,
while mortality from cervical cancer was 36% higher for African Americans (ISDH, 2018). Lower
income, educational status, and SES are also correlated with higher cervical cancer mortality
among Hoosiers.
In the 3 years between 2015 and 2018, just 68.3% of women in Indiana between 21 and
65 had received CCS (ISDH, 2018). The ISDH Strategic Plan includes a goal to increase this
proportion to 93% by 2023. Also, 54% of cervical cancers in Indiana are diagnosed at the late
stage, when it is more difficult to treat. Another goal of the Strategic Plan is to reduce the
percentage of cervical cancers diagnosed at a late stage to 40% by 2028 (ISDH, 2018).
County Data
Rates of cervical cancer, as well as mortality, are higher for those of low SES, uninsured
or underinsured, and racial or ethnic minorities. In Porter County, 92% of the population is white,
while African Americans make up 4% of the population and other races combined account for
the remaining 4% (U.S. Census Bureau, 2019). In addition, 10.4% of the population is Hispanic
or Latino. Also, 8.9% of Porter County residents are living below the poverty level. As for health
insurance coverage, 73% of Porter County residents have employer-provided health insurance,
10% direct-purchase insurance, 10% have Medicaid, 4% receive Medicare benefits, and 9%
have no health insurance coverage (Towncharts, 2020). These demographics differ significantly
from those of the patient population at the primary project site health clinic, located in Porter
County.
Data from the Clinical Agency Supporting Need for the Project
The evidence-based practice (EBP) project site is a non-profit Federally Qualified Health
Center (FQHC) with six clinics in Northwest Indiana that provides quality healthcare to all
(Health Clinic, 2020). The FQHC offers services regardless of insurance status and has income-
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based sliding-scale fees for patients with incomes up to 200% of the federal poverty level (FPL).
For uninsured women, income-based sliding scale fees for those with incomes less than 200%
FPL range from $0 to $50, and any lab tests are included in that fee (Health Clinic, 2020). In
addition, the FQHC participates in the Indiana Breast and Cervical Cancer Screening Program,
which provides access to free breast and cervical cancer screening and diagnostic tests to
qualifying women who are uninsured and underinsured (ISDH, 2020).
The clinic where this project was implemented is located in Porter County.
Demographics within the patient population seen at the clinic are 73% white, 15% African
American, 2% more than one race, 1% Asian, and the remainder other minorities or did not
state their race. Of the patients seen at the clinic, 36% are at 100% or less of the federal poverty
level (FPL), and an additional 16% are between 100 and 200% of the FPL. As to insurance
status, 25% of the clinic’s patients have private health insurance, 49% have Medicaid, 9%
Medicare, and 14% are uninsured. This patient population is at high risk for gaps in CCS and
increased mortality from cervical cancer due to the larger proportion of low-income individuals
and minorities compared with the surrounding community.
The FQHC’s value statement includes caring for all people regardless of their finances,
culture, or social condition (Health Clinic, 2020). In addition, one of the goals of the clinic is to
address income-based inequity. This project is in alignment with these company values.
Addressing care gaps is also important to stakeholders. Healthcare providers currently conduct
a daily huddle to discuss care gaps for patients who will be seen that day, and seek to address
these gaps during the visit, even if the patient is being seen for an unrelated reason (T.
Gamblin, personal communication, July 15, 2020). Care gaps include cancer screenings,
including CCS, and immunizations. As an FQHC, the project site has benchmarks to meet for
these care gaps, which include cervical, breast, and colorectal (CRC) cancer screening. If the
benchmarks are met and an increased percentage of their patient population is up to date for
CCS, the facility will receive an increase in funding. In addition, Pap testing is currently offered
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at all six locations of the FQHC. Gynecologists and Certified Nurse-Midwives do most of the
CCS, but the facility is working to involve more family practice physicians and nurse
practitioners in performing these screenings to increase uptake.
Purpose of the Evidence-Based Practice Project
The purpose of this EBP project was to increase CCS rates using Pap and HPV tests for
a primarily underserved population. The outcome measured was the number of women who are
due for CCS that actually attended an appointment and completed the CCS after receiving the
interventions. In particular, the interventions were an educational email followed by email and
phone reminders.
PICOT Question
Specifically, this project addressed the following PICOT question: Among (P) women
ages 21 to 65 who are patients at an FQHC, will (I) email education and reminder plus phone
calls (C) compared with the usual practice increase (O) cervical cancer screening uptake (T)
during a period of five months?
Significance of the EBP Project
This project is important because it has great potential to improve screening rates and
decrease cervical cancer cases in an at-risk patient population. It can improve patient outcomes
by decreasing the proportion of cervical cancers found at an advanced stage and increasing the
proportion found at an early, pre-cancerous stage which can be treated successfully. In the
vulnerable population at this health clinic, screening uptake is even lower than regional, state,
and national rates. Some barriers to CCS among those of low SES and minority populations
include lack of knowledge, cost, and lack of access to care (Plourde et al., 2016). This project
sought to address these barriers by providing education about cervical cancer and screening
tests and promoting screening at an FQHC which provides free and reduced-cost medical care
to patients regardless of insurance status. Morbidity and mortality from cervical cancer could be
decreased within this vulnerable population and many lives saved.
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CHAPTER 2

EBP MODEL AND REVIEW OF LITERATURE
Evidence-based Practice Model
Overview of EBP Model
For this EBP project, the Rosswurm and Larrabee Model for Change to Evidence-Based
Practice was utilized to guide its development, implementation, and evaluation. Mary Ann
Rosswurm and June Larrabee developed this model to assist practitioners in translating
research to practice (Rosswurm & Larrabee, 1999). The model guides practitioners through a
six-step process, from assessment to integration of an EBP protocol.
The first step is to assess the need for a change in practice. One must collect internal
data and compare them with external data to find a problem in current practice. Then, it is
necessary to discuss the problem with stakeholders, who may include patients, healthcare
providers, administrators, and quality improvement staff. Finally, one should identify the need for
a practice change from the findings (Rosswurm & Larrabee, 1999).
The second step is to link the problem with interventions and their associated outcomes.
During this step, the project manager should use standardized classifications to describe the
problem, then connect the problem with interventions and outcomes. As a result, choosing the
outcome indicators will flow from the process (Rosswurm & Larrabee, 1999).
Synthesizing the best evidence is the third step in the model. After defining the topic and
inclusion criteria, a literature search is conducted, followed by critical appraisal and synthesis of
the literature selected. Then it can be determined if there is a sufficient pool of evidence to
support a practice change. Feasibility of implementing the practice change within the proposed
setting also must be evaluated (Rosswurm & Larrabee, 1999).
The fourth step in the model is designing the practice change; this is generally in the
form of a protocol, procedure, or standard. It is important to consider the practice environment,
available resources, and stakeholder feedback, and ensure patients at the practice site are
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similar to those in the evidence base. The change in practice is more likely to be accepted if the
outcomes are relevant to the organization. Also, if the change will impact a large organization or
hospital, it should first be pilot tested in one or two units or clinics (Rosswurm & Larrabee,
1999).
Implementing and evaluating the change in practice is the fifth step of the EBP model.
The pilot study coordinator should be available to the staff and reinforce the practice change. In
this step, the data are analyzed for differences before and after the pilot. Based on feedback,
data, and recommendations, a decision is made whether to adopt the change, reject it, or adapt
it (Rosswurm & Larrabee, 1999).
The final step is to integrate and maintain the change in practice. The change, along with
supporting data, is communicated to stakeholders; in-services help communicate and facilitate
change. Following the organization’s processes facilitates integrating the change into standard
of care, while encouraging informal leaders can increase the diffusion of innovation (Rosswurm
& Larrabee, 1999).
Application of EBP Model to DNP Project
The Rosswurm and Larrabee Model for Change to EBP fits well with this DNP project,
best practice interventions to increase CCS rates. First, the project manager assessed the need
for a practice change. The Quality Director brought up clinical problems currently seen in the
FQHC where the project would be completed. She stated that the clinic’s CCS rates were lower
than the benchmark and much lower than the national goal. Data were collected regarding the
facility’s current interventions aimed to increase uptake and current screening rates. The need
to improve CCS rates was identified from these findings.
For step two, the problem of low screening rates was linked to possible interventions of
education and reminders. The desired outcome was improving CCS rates, so CCS completions
were decided upon as the outcome indicator. This is a benchmark and improving it will increase
funding to the FQHC.

CERVICAL CANCER SCREENING

9

For the third step, the literature search focused on interventions to increase CCS uptake.
Several databases were searched, and quantitative research was appraised and synthesized.
Sufficient systematic reviews and other high-level, high-quality data were found which
supported education and reminder interventions (Braun et al., 2015; Chan & So, 2015;
Jayasekara, 2020; Rees et al., 2018; Thompson et al., 2016). Feasibility, benefits, and risks of
evidence-based interventions at the project site were assessed. Email was selected as a costeffective method to provide education and reminders to the patient population.
For the fourth step, information and feedback were solicited from the Medical Director
and Quality Improvement staff, key stakeholders in designing the practice change. The proposal
was also sent to the clinic’s Board of Directors and presented to the managers at their weekly
meeting. Feasibility and sustainability of the interventions were considered along with the best
evidence. Consideration was given to similarity between populations in the literature and the
patient population at the practice site. Some of the literature addressed screening rates and
interventions specifically with minority women and those of low SES, similar to the practice site
population (Chan & So, 2015; Duffy et al., 2017; Dunn et al., 2017; Rees et al., 2018; Thompson
et al., 2016). A pilot test was planned at one clinic site for the phone intervention.
The fifth step, implementation and evaluation of the practice change, was conducted
during the fall and spring semesters. Due to facility restrictions in place for the Coronavirus
Disease 2019 (COVID-19) pandemic, the project manager was unable to meet with clinical staff
to keep them updated on the project and outcomes. However, the project manager did send out
emails to the appointment scheduling staff and healthcare providers with periodic updates,
providing her contact information and encouraging feedback. Data were collected before the
interventions, and continued to be collected after the interventions. At the conclusion of the
project, the data was presented to key stakeholders and a decision made on whether to
continue the intervention as a practice change, to adapt it, or to reject the change.
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The sixth and final step is integrating and maintaining the practice change. If the change
were adopted, the Quality Improvement Coordinator will be able to continue the email
interventions. The case managers or other staff members could continue the phone intervention
if this is decided upon.
Strengths and Limitations of EBP Model for DNP Project
The Rosswurm and Larrabee Model has many strengths for this DNP project. There is a
large body of evidence regarding interventions to increase CCS uptake. However, the project
site still had lower uptake rates than its target, and much lower than national goals. In this case,
the Rosswurm and Larrabee Model could help bridge the research-to-practice gap, which its
authors stated was the purpose in its development. The steps in the model provided a good
guide for this project. Assessment of the need for change based on internal and external data
was an important part of supporting the need for this EBP change. Also, a careful literature
search with appraisal and synthesis of the evidence was very important for this topic, to narrow
down and choose the best interventions for the situation and setting. As an FQHC, the project
site may have limited financial resources, so feasibility, including cost-effectiveness, was an
important consideration. In designing the practice change, it was necessary to consider the
demographics of the patient population at the project site and include evidence that examined
low SES and minority populations.
However, the model also has some limitations at this project site. Using standardized
classifications for the problem and interventions is not a helpful strategy in this instance.
Diagnostic codes do not really apply to screening rates, nor classification codes to education
and reminder interventions. In addition, the final step of integration and maintaining the change
will happen after the EBP project is completed. Therefore, the project manager will no longer be
at the site to help promote the change and encourage others to maintain it.
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Literature Search

Sources Examined for Relevant Evidence
A thorough search was carried out, including the Joanna Briggs Institute (JBI), Cochrane
Library, Trip medical database, Cumulative Index to Nursing and Allied Health Literature
(CINAHL), and Medline with Full Text search engines. Search terms used were cervical
screening, cervical smears, vaginal smears, Pap smear or Papanicolaou smear, uptake or
participate, and improve or increase. In all search engines, evidence was limited to that
published between 2015 and 2020, for the most recent evidence. JBI search terms were
cervical screening or Pap smear; nine results were returned. In the Cochrane Library, search
terms used were cervical cancer screening or Pap test; three results were found with this
search. The Trip database was searched utilizing the title limiter with search terms cervical
screening or Pap smear and uptake; results were limited to Guidelines, which returned 26
results. CINAHL was searched using Medical Subject Headings (MeSH) Cervical Smears or
keywords Pap test or cervical screen, uptake or participate, and increase or improve. Limiters of
English language, scholarly/peer reviewed, and female gender were applied; 143 results were
returned. Finally, Medline was searched with the MeSH headings Vaginal Smears or
Papanicolaou Test or keywords cervical screen, uptake or participate, and increase or improve.
The limiters of English language, scholarly/peer reviewed, and female gender were again
applied; 177 results were returned. A total of 358 pieces of evidence were found by searching
all five databases. Titles were screened for relevance, and abstracts read if the title seemed
applicable to the project. Inclusion criteria were articles which examined increase in uptake for
CCS, not just increase in knowledge. In addition, the articles had to discuss interventions to
increase CCS rates to be included. A total of 30 articles were found which fit the inclusion
criteria. Articles were then excluded which only discussed barriers to screening or which were
conducted in low or middle-income countries (see Figure 2.1).
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After the exclusion criteria were applied, nine pieces of evidence were selected for the
literature review, including one from JBI, seven from CINAHL, and one from Medline. Citation
chasing was completed for all nine reference lists, and one additional resource was found in this
way.
After review of the evidence and discussion with staff at the project site, it was decided
that email would be a cost-effective way to deliver education and reminder interventions, but
none of the articles found specifically addressed email education or reminders. An additional
literature search was conducted in Medline, utilizing the search terms cancer screening,
improve or increase, and email or e-mail or electronic mail. No date limiter was applied, to find
any older literature supporting this intervention, but limiters of scholarly/peer-reviewed and
English language were applied. A total of 277 results were returned; two articles were selected
which described email interventions to improve CRC and breast cancer screening rates.
Including the earlier search, a total of 635 pieces of evidence were identified through database
searches, from which a total of 11 were selected for the literature review, plus the one found
through citation chasing (See Figure 2.1).
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Figure 2.1

Included

Eligibility

Screening

Identification

PRISMA Flowchart

635 records identified through database
searching

93 duplicates removed

542 records screened

40 full text records assessed
for eligibility

11 studies included in literature review

502 records excluded

29 full text records excluded
because of
Only discussed screening barriers
Conducted in low/middle-income
countries

1 record identified through citation chasing
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Levels of Evidence
The JBI criteria were used to level the evidence for this literature review. The JBI Levels
of Evidence are designed to help the clinician make an initial quality assessment of that piece of
evidence. Based on the study design, findings can be initially ranked, and then qualified by the
evidence appraisal (JBI, 2014).
Among the 12 pieces of evidence selected for the literature review, nine fall within the
Level 1 category and three within the Level 3 category. Of the Level I evidence, two were Level
1a, systematic reviews (SRs) of Randomized Controlled Trials (RCTs); three were Level 1b,
SRs including RCTs and other study designs; and four were Level 1c, RCTs. The Level 3
evidence was all Level 3c, cohort studies.
Appraisal of Relevant Evidence
The JBI Critical Appraisal Tools were used to conduct a quality appraisal of the
evidence. JBI Critical Appraisal Tools are intended to evaluate the methodological quality of a
study and to assess for bias. These tools provide questions to rate a piece of evidence for any
bias in design, conduct, and analysis. JBI does not give a quality rating within the tools, instead
allowing the reviewer to determine whether to include or exclude the piece of evidence based
on answers to the questions (JBI, 2018).
Different tools are provided by JBI depending on the type of evidence being evaluated.
For this literature review, the Checklists for Systematic Reviews, Randomized Controlled Trials,
Quasi-Experimental Studies, and Cohort Studies were utilized. Each checklist has different
questions to evaluate the quality of that particular type of evidence; the checklists used for
appraisal in this review have between nine and 13 questions total (JBI, 2018).
Each question on the JBI Critical Appraisal Tools has a yes, no, unclear, or not
applicable designation. To further quantify the quality rating for each piece of evidence, the
number of “yes” responses for each piece of evidence were tallied. If three or fewer questions
were answered “no,” “unclear,” or “not applicable,” the piece of evidence was given a high-
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quality rating. If more than half could be answered “yes,” this was a good quality rating; and if
half or fewer could be answered “yes,” this was a low-quality rating. For the 12 pieces of
evidence selected, seven received a high-quality rating and five received a good-quality rating
(See Appendix A).
Level I Evidence
A good body of Level 1 evidence was found in this literature review. Five SRs were
included and four RCTs. The SRs provide a wealth of evidence supporting interventions to
improve CCS rates. Level 1 evidence is discussed in chronological order, apart from the article
on email interventions, which is included following the other evidence.
Braun et al. (2015). This RCT investigated the use of lay navigators to improve CCS
rates among Asian and Pacific Islander Medicare beneficiaries. Moloka’i, where this study was
conducted, is designated as a medically underserved area, where cancer screening rates are
lower, and mortality is higher, than the Hawaii state average. The study included 242
participants in the experimental group and 246 in the control group. The lay navigators assisted
the experimental group with services, including reminders by phone and mail and information
about screening for more than 95% of the patients. In addition, navigators helped with
appointment scheduling for 65% of patients. In 10 to 15% of cases, they also helped individuals
with paperwork, talking to healthcare professionals, transportation, payment and spouse or
childcare arrangements. The control group received education on nutrition and cancer from a
different healthcare entity (Braun et al., 2015). Surveys, which asked about screening
behaviors, were conducted with all participants at baseline and at the end of the study. After 24
months, CCS rates were 57.0% in the experimental group, compared with 36.4% in the control
group (p = 0.001). According to the JBI appraisal, this RCT was a Level 1b, high-quality
evidence, with 10 of 13 questions answered yes. Since this study was conducted with Medicare
beneficiaries, most participants were over age 65. However, about one-fourth of the population
was less than age 65, so results are likely applicable to this project. Although the study utilized
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lay navigators, this intervention was not feasible for the project. But it was possible to provide
email education, in addition to email and phone reminders, to fulfill some services provided by
the lay navigators. Appointment scheduling was also facilitated through a link to online
scheduling embedded in the emails and transferring patients to appointment scheduling staff
during the phone calls if they agreed to schedule.
Chan and So (2015). This SR examined the effectiveness of breast and CCS programs
in improving screening uptake for women of ethnic minorities. Five databases were searched in
this review, including Ovid Medline, CINAHL, Scopus, PsycINFO, and PubMed. A total of 10
RCTs were included in the review, four of which evaluated CCS programs’ effectiveness in
increasing Pap test uptake. These studies examined an outreach worker intervention, with a
letter and home visit with education, in addition to assistance with scheduling, clinic referral,
interpreter services, and transportation when necessary, compared with a direct mail
intervention and control group. Results showed a significant increase in Pap testing in both the
outreach worker intervention group (39%) and the direct mail intervention group (25%)
compared with the control group (15%) (Chan & So, 2015). Another study utilized three weekly
group educational sessions with an educational booklet and skill-building exercise, which
significantly increased Pap test uptake (61.7%) compared with the control group (38.3%), who
received the educational booklet after the exit survey. The third study utilized workshops, which
significantly increased CCS rates, with 71% for the intervention group compared to 22% for the
control group. The final study had three intervention groups: one with the full AMIGAS
programme, including a video and flip chart; one using the flip chart only; and one utilizing just
the video. All three groups showed a statistically significant increase in Pap test uptake
compared with the control group: full AMIGAS programme at 52.3%, video only at 41.3%, flipchart only group at 45.5%, and the control group at 24.8% uptake (Chan & So, 2015). Notably,
all interventions were culturally relevant, in the participant’s language, and included key
messages about cervical cancer and screening. According the JBI criteria, this study falls into
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the Level 1a category, and is of high quality, 11 out of 11 questions answered yes. This study
was included since much of the patient population at the project site is from racial and ethnic
minorities.
Thompson et al. (2016). This RCT compared a low-intensity intervention and highintensity intervention with a control group on CCS rates in a population of rural Latina women
receiving care at an FQHC. The study included 443 participants, with 150 randomized to the
low-intensity group, 146 to the high-intensity group, and 147 to the control group. The lowintensity intervention was a Spanish-language video that was culturally appropriate, with
information on CCS, recommendation to receive screening, and information on low-cost clinics
where CCS could be sought. For the high-intensity screening, a promontora (lay health worker)
provided a home visit that included an education session incorporating the video, as well as
scheduling an appointment or committing to do so. The promontora also gave participants a
local resource sheet, reminder refrigerator magnet and appointment card and answered any
questions. Participants in the control group received usual care, with information on CCS from
their health care providers. Measurement was through a survey to determine Pap test uptake
after seven months. The high-intensity arm had a significantly higher proportion of women
(53.4%) who received a Pap test compared with the low-intensity arm (38.7%) and the usual
care arm (34.0%), but there was no significant difference between the low-intensity and usualcare arms (Thompson et al., 2016). This RCT was appraised as Level 1c, with a high-quality
rating,11 out of 13, by the JBI criteria. Having been conducted within an FQHC, it provides good
evidence for this project and support for culturally appropriate interventions.
Duffy et al. (2017). This rapid review was conducted to find evidence for interventions to
improve uptake of cancer screening, especially among underserved populations. A literature
search of PubMed was conducted for the rapid review. The authors found 68 articles in total,
with 18 on CCS, including RCTs, quasi-RCTs, and non-randomized controlled trials. Five of the
studies found a significant increase in CCS uptake with reminder letters, some of which also
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included education, or phone calls, while two found increases that were not statistically
significant and two found no significant difference between uptake following letters and phone
calls. One study showed a significant increase in CCS rates in an area which received multiple
outreach interventions compared with the usual care control area (84% compared to 71%),
though this was not a randomized study (Duffy et al., 2017). Self-sampling resulted in a
significant increase in CCS in five of the studies, and a non-significant increase in one additional
study. Fixed appointment times also increased attendance rates for CCS in one study. Finally,
one of the studies found an increase in CCS (43% versus 35%) with home visits. Reminders,
endorsement by family practice providers, and more acceptable screening tests were most
consistently found to improve uptake of screening (Duffy et al., 2017). By the JBI criteria, this
review is Level 1b and appraised as good quality, with eight of 11 points. Unfortunately, selfsampling was not an available intervention at the project site. However, the focus on
underserved populations was very applicable to this EBP project.
Kitchener et al. (2018). This cluster randomized trial was conducted to evaluate the
effects of a two-phase intervention on CCS rates in young women. Conducted in both Greater
Manchester and Grampian, the trial also evaluated feasibility of the interventions. The study
included 20,879 participants in 276 practices. In phase one, 138 practices with 10,461 women
were randomized to receive a mailed educational leaflet three months prior to the usual
invitation to cervical screening, while 138 practices with 10,418 women were randomized to the
control group, receiving usual care with the mailed invitation. The 103 practices in Manchester
had the option for online booking, so these practices were also randomized to online booking (n
= 52) or no online booking (n = 51) in Phase 1 (Kitchener et al., 2018). During Phase 2, women
who had not yet received screening were re-randomized to a control group or one of five
interventions: timed appointments, nurse navigator, self-sampling sent, self-sampling offered, or
a choice between nurse navigator and a self-sampling kit. During Phase 1, there was a small,
non-significant increase in CSS after 6 months in the group that received the leaflet (31.13%)
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compared with the control group (30.63%; p = 0.747) and the group that received the online
booking (28.82%) versus the control group in Manchester (26.64%; p = 0.242) (Kitchener et al.,
2018). In Phase 2, CCS uptake increased significantly in the group sent self-sampling kits at 12
months (p = 0.001) and 18 months (p = 0.012) and in the timed appointments intervention group
at 12 months (p = 0.001). This RCT was appraised as Level 1c, with a good quality rating, eight
out of 13. This RCT had a different population from this project, since it assessed women due
for their first CCS rather than those who are overdue. However, some of the interventions,
including online booking and educational information, were utilized in this EBP project.
Rees et al. (2018). This SR examined RCTs and quasi-RCTs with evidence on
interventions which increased CCS among those with low SES. Medline, CINAHL, Embase, and
the Cochrane Register of Controlled Trials were searched for this review; the OpenGrey
database was also searched for grey literature. From the literature search, 16 studies were
selected for review and analysis. In addition, this review built on an earlier review from 2010 on
the same topic, which included 13 studies (Rees et al., 2018). HPV self-test kits were found to
significantly increase CCS uptake in two studies. In seven of the studies, use of lay health
advisors (LHAs) improved CCS rates significantly; one additional study showed a nonsignificant increase, and one showed no significant difference between individual and group
education by LHAs (Rees et al., 2018). In three of the studies, mailed reminders significantly
increased CCS, whereas phone calls were effective in two studies, and mailed reminders in
addition to phone calls improved CCS in three of the studies. Several studies utilized mixed
interventions; two of these indicated significant increases in CCS, three had increases that were
not statistically significant, and three found no significant difference in screening. In addition, the
evidence suggests that letters with simpler communication, key messages, and follow-up phone
calls for support and evaluation of barriers increased their effectiveness (Rees et al., 2018). The
JBI appraisal found this study to be a Level 1a with a high-quality rating, 10 out of 11. The focus
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on low SES groups and information on phone calls, letters, and education was helpful in
developing this EBP project.
Saei Ghare Naz et al. (2018). An SR was undertaken for the purpose of assessing the
efficacy of educational interventions on CCS behavior. The Cochrane Library, Web of Science,
Science Direct, PubMed, and Scopus databases and Google Scholar were searched for
evidence, and 37 articles were selected for inclusion. The results indicated that in-person
education improved CCS rates significantly in seven studies, with an additional seven studies
showing non-significant increases. In addition, a mailed letter and educational video were found
to significantly increase CCS rates. A phone intervention had a non-significant increase, and
other studies showed increases in knowledge or decreased barriers to CCS, but CCS rates
were not reported (Saei Ghare Naz et al., 2018). The study was appraised by JBI criteria as
Level 1b, good quality, seven out of 11. This review gives good support for a variety of
educational interventions to increase CCS.
Jayasekara (2020). This JBI Evidence Summary reviewed evidence regarding CCS
uptake with the Pap test. A structured rapid review literature search and search of evidencebased health care databases were conducted. Five pieces of evidence were selected from the
search, including one SR with meta-analysis, two SRs, and two observational studies. Two of
the SRs supported many educational strategies, including mailed materials, individual and
group sessions, and media outreach; culturally appropriate education was shown to be
effective. Telephone and mailed reminders were also supported by one of these SRs. This SR
and the SR with meta-analysis also found evidence that HPV self-testing increases CCS
uptake. It should be noted that two of these SRs are also included separately as part of the
body of evidence and summarized above (Rees et al., 2018; Saei Ghare Naz et al., 2018). In
addition, an observational study found that invitation letters increased Pap test uptake; the
proportion of women who had never had a Pap test decreased by 13.72% (Jayasekara, 2020).
The other observational study stated that starting CCS at 30 years is most cost-effective but
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recommended that nations with higher cervical cancer rates start screening earlier. This
evidence is Level 1b by JBI leveling, and appraised as high quality, nine out of 11. More support
is found for reminders and education of various types in this Evidence Summary.
Chaudhry et al. (2007). This article was included to support effectiveness of email
interventions for this EBP project. The purpose of this RCT was to determine feasibility of a
Web-based information system for staff and its effect on mammography rates, assess the effect
of patient reminders for mammography scheduling on annual physical exam rates, and compare
efficacy of email and U.S. mail reminders. The sample population was women age 40 to 75 who
were patients of a large group practice and due for mammography within three months. Women
were randomly assigned to usual care (n = 3339) or to receive the intervention (n = 3326), a
reminder letter from that patient’s physician with a brochure on preventive services. Patients in
the intervention group who were employees of Mayo Clinic were randomized to also receive
either a US mail or email reminder through their work e-mail. In addition, participants received a
second reminder one month later and then a phone call one month after that if they did not
respond to earlier reminders. Annual mammogram screening rates were measured for each
group at the end of the one-year study period. A significantly higher proportion of women in the
intervention group (64.3%) had mammograms than in the control group (55.3%; p < 0.001)
(Chaudhry et al., 2007). Among the Mayo Clinic employees, 72.2% in the email group received
a mammogram, compared with 68.1% in the US mail group and 57.5% in the control group.
Both email and U.S. mail interventions had a statistically significant increase over the control
group (p < 0.001), but no significant difference was found between email and U.S. mail (p =
0.24). By the JBI appraisal, this article was Level 1c, good quality, eight out of 13. It provides
support for email reminders as a cost-effective measure to improve mammography screening
rates, which could be generalized to CCS to support email as comparable with U.S. mail
reminders.
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Level III Evidence
From the literature search, three cohort studies, which are Level 3 according to JBI,
were selected for inclusion in the body of evidence for this EBP project. The first two are
reviewed in chronological order, and the last one pertains to email interventions to increase
CRC screening rates.
Tavasoli et al. (2016). In this cohort study, the purpose was to measure the
effectiveness of mailed invitation and reminder letters to increase CCS among women in
Ontario ages 30 to 69. The sample included 99,278 women in the intervention group, who were
compared with a historical non-intervention cohort of 130,181 women from one year earlier. The
intervention was an invitation letter, which included CCS information. The women in the
intervention group who had not received a Pap test after 4 months were then sent a reminder
letter. Rates of Pap testing in this group were measured 9 months after the invitation letter. This
was compared with Pap testing rates in the historical cohort during the 9-month period a year
earlier, when they were eligible for CCS. Women who received the intervention were
significantly more likely to have a Pap test (14.1%) during the 9-month period than those who
did not (8.5%; OR: 1.8, 95% CI 1.7-1.8) (Tavasoli et al., 2016). This study was appraised as a
Level 3c, high quality, eight out of nine, by the JBI criteria. Although a cohort study is not as
strong a design, the large sample size in this piece of evidence provides good support for a
mailed intervention.
Dunn et al. (2017). This was a matched cohort study conducted to evaluate efficacy of
CARES, a community-based program, to increase CCS and breast cancer screening uptake for
underscreened or never-screened women. The study included 331 women in the intervention
group, and 969 matched controls. The intervention included group education sessions which
were language-specific; peer leaders and program staff facilitated the sessions. Participants
were also assisted with screening, and peer leaders contacted them several months later to
encourage and help with scheduling CCS if they had not yet attended. CCS uptake for
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participants and controls was obtained from a national cancer registry. CCS uptake rates were
26% in the intervention group, while only 9% of the control group had CCS (OR = 5.1; 95% CI =
2.4, 10.9) (Dunn et al., 2017). This article was rated Level 3c by the JBI criteria, of high quality,
nine out of 11. More support is provided for the effectiveness of patient education with this piece
of evidence.
Muller et al. (2009). This cohort study was conducted to evaluate efficacy of email
reminders to increase rates of CRC screening. A sample of 2100 patients was randomized to a
control group (n = 494), letter intervention (n = 458) or email intervention (n = 457). From the
original sample, some patients were found to be ineligible during the time delay between
randomization and start of the intervention, which accounts for the difference between the
sample size and total group numbers. The letter intervention group received one letter reminder,
the email intervention group received one email reminder through the HMO’s secure email
system, and the control group received usual care. The proportion of patients completing CRC
screening within 90 days of the reminders was the outcome measured. The results showed that
22.7% of the patients who received the email reminder obtained CRC screening, compared with
23.6% of the letter reminder group and 7.8% of the usual care group (Muller et al., 2009). The
letter and email interventions both achieved statistically higher response rates than the usual
care group (p < 0.0005), but no significant difference was found between email and letter
reminders (p = 0.711). By the JBI criteria, this article appraised as Level 3c, good quality, eight
out of 11. This study provides support for the efficacy of an email intervention and its
equivalence to letter reminders, which were found quite effective to increase CCS rates by the
other evidence cited above.
Construction of Evidence-based Practice
Synthesis of Critically Appraised Literature
The body of evidence provides support for many types of interventions to increase CCS
rates. Different types of patient education were found to significantly increase CCS rates in most
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of the literature examined (Chan & So, 2015; Dunn et al., 2017; Jayasekara, 2020; Kitchener et
al., 2018; Saei Ghare Naz, 2018; Thompson et al., 2016). Specifically, mailed educational
materials increased uptake significantly in a few studies and in several systematic reviews
(Chan & So, 2015; Duffy et al., 2017; Jayasekara, 2020; Kitchener et al., 2018; Saei Ghare Naz,
2018). Rees et al. (2018) reported that phone education, support, and evaluation of barriers
were also effective to improve CCS rates. Several studies also supported language-specific,
culturally appropriate education as part of a program which increased CCS rates (Chan & So,
2015; Dunn et al., 2017; Jayasekara, 2020; Thompson et al., 2016). In addition, Chan and So
(2015) reported in their SR that education strategies were more effective when they included
key messages about cervical cancer and screening.
Much of the literature also supports patient reminders to increase uptake of CCS (Braun
et al., 2015; Chaudhry et al., 2007; Duffy et al., 2017; Jayasekara, 2020; Muller et el., 2009;
Rees et al., 2018; Tavasoli et al., 2016). Specifically, mailed reminders were a supported
intervention in much of the literature reviewed (Braun et al., 2015; Chaudhry et al., 2007; Duffy
et al., 2017; Jayasekara, 2020; Muller et el., 2009; Rees et al., 2018; Tavasoli et al., 2016). In
addition, phone reminders were reported effective to increase CCS uptake (Braun et al., 2015;
Duffy et al., 2017; Rees et al., 2018). Chaudry et al. (2007) and Muller et al. (2009) found that
email reminders were also effective to increase cancer screening uptake, and their efficacy was
not statistically different from that of mailed reminders. Multimodal interventions were often
found to be more effective in improving uptake than a single intervention (Braun et al., 2015;
Chan & So, 2015; Duffy et al. 2017; Rees et al., 2018; Thompson et al., 2016).
Best Practice Model Recommendation
The reviewed literature identified education and reminders as best practice to address
low CCS rates. A variety of educational methods are supported by the literature. Email is a costeffective method to deliver education on CCS at the EBP project site, so this is an appropriate
initial intervention to encourage women to obtain screening. The email should include key
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messages and simple communication for the best impact and be sent in the patient’s primary
language. Multiple interventions were often more effective than a single intervention. Reminders
by several methods had good efficacy for improving CCS rates. In some facilities, an automated
phone message has been utilized as a reminder, but this is not available at the project site.
However, a follow-up reminder email is a cost-effective method to deliver reminders at the
project site for patients who do not respond to the initial educational email and should be
included as an additional way to reach this patient population. Finally, phone calls were shown
to be quite effective in improving uptake of CCS, and therefore should be included as an
additional, more personal, intervention for those patients who do not respond to the second
email. The phone call also provides an opportunity to discuss concerns and address barriers to
women getting CCS.
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CHAPTER 3

IMPLEMENTATION OF PRACTICE CHANGE
This chapter will include a description of the process employed to implement this EBP
project, describing the participants and setting, interventions employed, comparison group,
outcome measurements, and time for completion. The EBP project involved developing best
practice to improve CCS rates among underserved women who are clients of a health center in
Northwest Indiana. This patient population experiences many barriers to obtaining CCS,
including lack of knowledge, lack of access to care, cost, transportation, and fear. Through this
EBP project implementation, the goal was to reduce the barriers that the clinic could address
and increase CCS rates. Through increasing CCS, the population served would be expected to
subsequently have reduced incidence of cervical cancer morbidity and mortality. The aim of this
project was to increase CCS rates and address the following PICOT question: among (P)
women ages 21 to 65 who are patients at an FQHC, will (I) email education and reminders plus
phone calls (C) compared with the usual practice increase (O) cervical cancer screening uptake
(T) during a period of five months?
Participants and Setting
This EBP project was conducted at an FQHC in Northwest Indiana. An FQHC provides
high-quality care to all patients regardless of insurance status, income, or ability to pay,
especially benefiting individuals who are of low SES, uninsured, and underinsured. Important
stakeholders in this practice change include the Director of Quality and Patient Safety, Chief
Medical Officer, family practice and gynecologic providers, case managers, and appointment
scheduling staff. The project manager is involved in the practice change as well, although not an
employee of this FQHC.
Patients who were due for CCS were identified by review of the population health tool at
the clinic in August 2020, determined by age, medical history, and overdue status for CCS. The
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phone intervention was only completed at the Portage location as a pilot, due to feasibility.
Phone calls were made to those patients who have a Portage family practice physician or nurse
practitioner listed as their usual provider, to capture those who were regular patients of the
health clinic. Female patients ages 21 to 65 who had not received a Pap test within the past 3
years, or ages 30 to 65 who had not received a Pap plus HPV test within the past 5 years, met
the inclusion criteria for this project. The population included only active patients of the FQHC,
defined as patients who have completed at least one visit at the health center in the past 12
months. Patients who had a hysterectomy with removal of cervix, congenital absence of a
cervix, or were on hospice care were excluded. Also, patients who did not have an active email
address on file with the health center were excluded from the interventions.
Pre-Intervention Group Characteristics
The inclusion criteria for this EBP project included women ages 21 to 65 who had no
Pap test recorded in the past 3 years and women ages 30 to 65 who did not have a Pap plus
HPV test recorded in the past 5 years. Once these criteria were applied and participants were
selected, participants in the project included women who varied in age from 24 to 65. Racial
characteristics of the participants included Caucasian women, Black women, Asian women,
American Indian or Alaska Native women, more than one race, and some whose race was not
reported. For ethnicity, some of the patients reported Hispanic or Latino ethnicity, some women
were Non-Hispanic, and some did not report their ethnicity. Insurance status of these patients
varied among the participants from private insurance, Medicaid, Medicare, and self-pay or
uninsured.
An email was written, with input from quality improvement staff, which included
education regarding the importance of CCS and information on Pap and HPV testing (see
Appendix B). The email was evaluated for reading level, with a goal of a sixth-grade reading
level to make it accessible for all patients. However, the final approved version included some
medical terms, per the request of the Medical Director, which slightly increased the reading
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level. In addition, the email included the clinic phone number and a link to schedule an
appointment online, as well as a link to an online fact sheet about CCS tests (see Appendix C
for fact sheet). The email was translated into Spanish and the fact sheet sent as a Spanish
version for patients who indicated Spanish as their primary language. A link to the website
where the educational fact sheet was obtained is included in Appendix C and the Spanish
version of the fact sheet can be obtained from the website (Office on Women’s Health, 2018).
The email was sent out to all patients who were due for CCS within the FQHC, at all six
locations in Northwest Indiana. The project manager and Quality Improvement Coordinator sent
the email in mid-September through the FQHC’s secure healthcare software. A total of 5,401
emails were sent out, 5,242 in English and 159 in Spanish. Four hundred fifty-three of those
sent in English and 20 in Spanish generated an error message, indicating the email had not
gone through; so, a total of 4,928 emails were successfully sent.
Before the first email was sent out, the appointment scheduling staff was informed about
the project and educated to anticipate an increased number of calls to schedule CCS. The dates
of the emails and phone calls were provided to the appointment scheduling staff. Data were
collected on how many patients scheduled and attended appointments for CCS after the email
was sent out; 59 patients completed CCS and an additional 60 scheduled appointments but had
not yet completed them. In addition, the number of emails received and opened was tracked;
2,109 emails sent in English and 65 in Spanish were opened. Those patients with emails that
generated an error message were removed from the list before the second email was sent out.
Participants who had not scheduled an appointment for CCS within two weeks after the initial
email received a reminder email through the same software (see Appendix D). The reminder
email was sent two weeks after the educational email. The reminder email was also sent in
Spanish to patients who indicated Spanish as their primary language. The links to online
scheduling and the fact sheet were also included in the reminder email. However, the link was
not included in the Spanish-language emails, since it would only appear in English and link to
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the English-language scheduling site. The second email was sent out to 4,809 patients and 32
of these emails received an error message. 4,777 were sent successfully to patients of all six
clinics. For the second email, 1,624 sent in English and 64 sent to Spanish-speaking patients
were opened.
Following the email reminder, the number of patients who scheduled and attended CCS
appointments continued to be tracked, with a total of 49 additional participants completing and
59 scheduling CCS. The phone calls were initially planned to start in mid-October. However,
due to staff assisting with the project being out of the office due to health concerns, and then
difficulties with getting a phone line set up, the start of phone calls was delayed by three weeks.
Starting in early November, reminder phone calls were made to the patients at the Portage
location who had not yet made an appointment for CCS. Phone calls were made to patients
whose usual provider is one of the family practice clinicians at the Portage site. Patients of the
Portage site whose usual provider was not a clinician at that site received a third email (see
Appendix E). Phone calls were made to 554 participants. The phone calls were also an
opportunity to address any concerns and some of the barriers that participants experienced to
scheduling or attending CCS. The barrier of lost work time was addressed by mentioning the
availability of evening and Saturday appointments. The cost barrier was addressed by
discussing sliding scale fees to provide free or low-cost screening. Sending an educational
email and answering any questions raised by the patients in the phone calls assisted in
resolving the knowledge barrier. Also, any fears or concerns expressed could be answered, to
help with the barrier of fear about the test or a cancer diagnosis. In addition, the calls were
transferred to the appointment scheduling staff if the participant agreed to schedule that day. If a
phone message was left, privacy and confidentiality were maintained with a request to call the
clinic to schedule their test, but no diagnosis-specific information was included in the message.
The approved script used for the phone calls made, as well as for messages left, is included in
Appendix F.
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Comparison

Data driving this practice change included low CCS rates among underserved,
uninsured, or underinsured women who are clients of an FQHC in Northwest Indiana. CCS
rates of these women pre-intervention were compared with CCS rates post-intervention. Also,
CCS rates following each intervention were compared to evaluate the efficacy of multiple
interventions. In addition, due to potential effects of the COVID-19 pandemic on patients
seeking routine health care, rates of CCS in a historical group of patients who received care at
this FQHC as of one year before this project, in October 2019, were compared as well. As part
of its usual practice, the facility sent out a reminder email to all patients due for CCS in May
2019. Including the historical comparison group will capture CCS rates following this
intervention.
Outcomes
The primary outcome of this project was the increase in CCS rates in the population of
eligible women who receive care at the Porter County location of this FQHC. This was analyzed
in comparison with the uptake in patients from 2019 utilizing the Chi-square test for
independence. Secondary outcomes included the CCS uptake following each intervention, to
compare the additional effect of the second email and phone call, which were analyzed using
McNemar’s test. In addition, CCS completions in women who are patients at the other five
locations were collected as a secondary outcome, since they received the email education and
reminder email. These data were collected through chart reviews and reported as frequencies.
In addition, through a post-visit survey, data were collected on relevance of the education, ease
of making the appointment, and the healthcare visit; these were intended to be analyzed as a
secondary outcome and reported as frequencies.
Time
Interventions and measurement of outcomes for this project were expected to take
approximately five months to complete. The educational email was sent out in mid-September.
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Because many women targeted were mothers with young children, September seemed a good
time to start, since they would have their children back in school and hopefully have time for
their own healthcare appointments. Following the email, two weeks were needed to allow time
for women to schedule a CCS appointment according to their preference and collect data on
those who were still overdue. The reminder email could then be sent, and two more weeks
allowed for time to schedule before evaluating uptake again and beginning the phone calls.
Starting the phone calls in mid-October was initially planned, to provide several weeks in which
to complete the calls prior to the holiday season. However, starting the phone calls in early
November allowed them to be completed by the end of the first week in December.
Protection of Human Subjects
Protection of human subjects was maintained throughout this EBP project. When
patients enroll at this FQHC, they sign a general consent to participate in research and quality
improvement projects that do not pose any risk of harm to themselves. Therefore, individual
consent from participants was not necessary for this project. The project manager successfully
completed an ethics course as part of the requirement of Valparaiso University’s DNP
curriculum. In addition, the project manager completed the Collaborative Institute Training
Initiative (CITI) program entitled “Social Behavioral Educational Research: Basic Course.” An
Institutional Review Board (IRB) Questionnaire was completed to determine what review would
be needed for this project. This EBP project was determined to be exempt from IRB approval
by Valparaiso University. Approval was also obtained from the health clinic’s Board of Directors
before proceeding with implementation of the project.
All data and confidential information were kept in a secure location. All information was
protected to maintain standards of research ethics and the Health Insurance Portability and
Accountability Act (HIPAA). Any data on demographics and CCS rates which was stored
outside of the Electronic Health Record had patient identifiers removed. In addition, information
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password protected, so any information uploaded was protected there, as well.
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CHAPTER 4
FINDINGS

This chapter will present the results of the EBP project. The purpose of this EBP project
was to determine whether email education and reminders plus phone calls would increase CCS
rates among the patient population at the primary Porter County site of an FQHC over a fivemonth period compared with the usual practice of sending one reminder email. The primary
outcome, rates of CCS for the intervention group, were determined through chart review and
compared with rates of CCS at the project site during a five-month period in 2019. A secondary
outcome to be examined compared effectiveness of each email and phone call intervention in
improving CCS. In addition, uptake of CCS among patients at all six clinics of the FQHC, who
received only the email interventions, was reported as a secondary outcome. This chapter will
include details of participant demographics, outcomes, and statistical analyses.
Participants
Eligible participants were identified by chart review in August 2020. Inclusion criteria
were female patients between ages 21 and 65 who had no Pap test in the past 3 years, or those
between ages 30 and 65 who did not have a Pap test plus HPV in the past 5 years. In addition,
only patients whose usual provider was a primary care provider (PCP) at the primary project site
were selected for inclusion. The project manager and Quality Improvement Coordinator
reviewed charts to identify participants for inclusion based on age, past medical history, usual
provider, and date of last Pap test and HPV. Patients were excluded who had no email address
on file, did not speak Spanish or English, had a hysterectomy or were on hospice care.
Following this review, 554 participants were identified for inclusion in the sample. Demographic
information on participants collected from charts included age, race, ethnicity, and insurance
status.
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While the phone call intervention was being completed, it was discovered that 60 of the
participants were up-to-date for their CCS with a provider outside of the project site, so these
participants were excluded from the sample since only those overdue for CCS were to be
included. In addition, 16 of the participants stated they had a hysterectomy, so they were
excluded, since they would have initially been excluded had the hysterectomy been found in
their medical history from the chart review. Finally, three of the participants said they had moved
out of the area, so they were excluded since they would not be expected to complete CCS at
the project site but were reminded to schedule CCS with a new provider in their local area. After
these participants were excluded, the intervention group included 475 participants.
The comparison group from 2019 was identified through chart review in August 2020
and included participants with the same criteria as the intervention group: female patients
between age 21 and 65 who were overdue for CCS, defined as no Pap test in the past 3 years,
or women age 30 to 65 who did not have a Pap test plus HPV in the past 5 years; and those
whose usual provider was a PCP at the project site. Patients who had no email address on file,
had a hysterectomy, were on hospice care, or spoke a language besides Spanish or English
were excluded. 634 participants were identified for the comparison group.
Demographic Data
The demographics of the intervention group were quite similar to the comparison group.
Racial characteristics of the intervention group were 80.4% white, 9.7% African American, 1.3%
More than One Race, 0.8% Asian, 1.1% Other, and 6.7% did not specify their race. Similarly,
the comparison group from 2019 was 79.2% White, 10.1% African American, 2.2% More than
One Race, 0.9% Asian, 0.6% Other, and 6.9% did not specify race. Compared with
demographic data for Porter County, which is 92% White, 4% Black, and 4% other races, the
participant population for both groups has a higher proportion of minorities than the county (U.S.
Census Bureau, 2019).
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Ethnicity between the two groups was also similar, with 8.4% Hispanic/Latino, 60.0%
Non-Hispanic, and 31.6% who did not specify for the intervention group. The comparison group
was 10.9% Hispanic or Latino, 58.4% Non-Hispanic, and 30.8% did not specify ethnicity. The
ethnicity of the project participants is similar to that of Porter County as a whole, which is 10.4%
Hispanic or Latino (U.S. Census Bureau, 2019). Language was very similar between groups,
with 98.9% English-speaking and 1.1% Spanish-speaking in the intervention group and 99.1%
English-speaking and 0.9% Spanish-speaking in the comparison group. A Chi-square test of
independence was calculated comparing age for the two groups. No significant relationship was
found (X2 (41, N = 1109) = 39.739, p > .05. Age does not appear to be associated with
membership in the comparison or intervention group. Average age was quite similar for the
intervention group (M = 43.14, SD = 12.32, n = 475) and the comparison group (M = 42.83, SD
= 12.11, n = 634). For both groups, participants ranged in age from 24 to 65.
However, insurance status for the two groups was somewhat different, with 33.9%
private insurance, 43.4% Medicaid, 18.1% Self Pay, Sliding Fee Scale or Uninsured, 1.1%
Medicare, and 3.6% other Government Insurance for the intervention group. The comparison
group had a lower percentage with Medicaid but more with private insurance and Self Pay:
37.5% private insurance, 34.4% Medicaid, 25.1% Self Pay, Sliding Fee Scale or Uninsured,
0.6% Medicare, 2.2% other Government Insurance, and 0.2% other. This difference could be
due to the pandemic; with rising unemployment in 2020, more Hoosiers may have qualified for
Medicaid than in 2019. Compared with Porter County’s population, a higher proportion of the
project population had Medicaid or no insurance and fewer had private insurance or Medicare
(Towncharts, 2020).
Changes in Outcomes
The increase in CCS for the intervention group was statistically significant in relation to
CCS uptake for the comparison group. In addition, a greater number of participants completed
CCS following each of the three interventions, with subsequently greater uptake after each
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successive intervention. Primary and secondary outcomes, statistics, and frequencies will be
discussed.
Statistical Testing and Significance
Statistical tests include Chi-square to determine the change in CCS uptake from the
comparison group of patients to the intervention group. The Chi-square test of independence
was selected to determine whether the difference in CCS uptake between the two groups was
due to the interventions as opposed to sampling error or chance (Cronk, 2018). In addition,
McNemar’s Test was conducted to compare the effectiveness of each intervention: the
educational email, second reminder email, and phone call. McNemar’s Test was chosen since it
could show a change in the proportion of participants who completed CCS after each
intervention (Glen, 2015). Both Chi-square and McNemar’s Test are designed for use with
nominal data such as that collected for this project. The overall CCS uptake at all six clinics
were reported as frequencies. Finally, the results from post-visit patient surveys were collected
via chart review and examined.
Findings
Primary Outcome
Cervical Cancer Screening Rates at Primary Site. This project found that 16.4% (n =
78) of the participants completed their CCS following the interventions. This was increased from
the comparison group, which had 11.4% (n = 72) complete CCS during the 5-month period
following the email that was sent out in 2019 (See Figure 4.1). The difference in CCS rates
between the comparison group and the intervention group was analyzed using a Chi-square test
of independence, which showed a significant increase X2 (1, N = 1109) = 5.96, p < .05.
Secondary Outcomes
Increased Rates with Interventions. A total of 78 participants in the intervention group
completed CCS during the study period. This included 13 participants who completed CCS after
receiving the first email, 27 after the second email, and 38 following the phone calls (See Figure
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4.2). The effectiveness of each intervention was analyzed utilizing McNemar’s test, which found
a significant increase in CCS after the second email (X2 = 25.04, df = 1, N = 475, p = .000).
McNemar’s test also showed a significant increase in CCS completions after the phone call
intervention (X2 = 36.03, df = 1, N = 475, p = .000).
Cervical Cancer Screening Rates at all Six Clinics. Patients of all six clinics within the
FQHC received the two emails and patients of the primary site with a usual provider who was
not one of the clinic’s PCPs received a third email. Patients who had at least one visit at the
FQHC in the past 12 months received the emails. Out of the total 4,374 participants who only
received emails, 7.15% (313) completed CCS during the 5-month period of data collection. This
does not include usual patients of the pilot site who also received the phone calls.
Post-visit Survey Data. All clients of the FQHC receive a link to a post-visit survey
following each appointment. For those participants who completed CCS, their survey responses
in relation to making the appointment and educational materials available were examined.
However, only nine patients completed the post-visit survey, and not all had a response to the
question about educational materials. Therefore, it was determined that insufficient data were
available for analysis.
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Figure 4.1
Cervical Cancer Screening Completion Rates
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Figure 4.2
Cervical Cancer Screening Completions Following Each Intervention
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CHAPTER 5
DISCUSSION

The purpose of this EBP project was to determine whether an educational email, in
addition to a reminder email and phone call, would increase CCS rates in the population at an
FQHC clinic in Porter County compared with usual practice. Specifically, the project was
designed to answer the PICOT question: among (P) women ages 21 to 65 who are patients at
an FQHC, will (I) email education and reminders plus phone calls (C) compared with the usual
practice increase (O) cervical cancer screening uptake (T) during a period of five months? Data
analysis indicated that there was a significant increase in CCS completions compared with a
similar group of patients from the same clinic in 2019. Secondary outcomes included examining
whether adding the second email significantly increased CCS completions as opposed to just
sending one email, and whether the phone call had increased efficacy compared with uptake
following the two emails. Patients of the other five clinics also received the emails; the rate of
CCS uptake in that population was also collected and reported as a frequency.
This chapter will discuss the findings of the EBP project in relation to the body of
literature. In addition, strengths and limitations of the project and its implementation are
covered. Implications for future practice, theory, research, and education will be addressed.
Explanation of Findings
Primary Outcome
The primary outcome of this EBP project found that an educational email, reminder
email, and phone call increased rates of CCS (16.42%) compared with the usual practice of a
single email (11.36%). The increased uptake associated with the interventions was significant
X2 (1, N = 1109) = 5.96, p < .05). This is concordant with evidence found in the literature search.
For example, an RCT conducted by Braun et al. (2015) found that education, mailed, and phone
interventions by a lay navigator were effective to increase CCS rates (57.0%) compared with a
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control group (36.4%, p = .001). Reminder letters were also found to increase CCS uptake in
several SRs and RCTs (Duffy et al., 2017; Jayesakara, 2020; Kitchener et al., 2018; Rees et al.,
2018; Saei Ghare Naz, 2018). A large cohort study (N = 99,278) also found that mailed
reminders were effective to increase CCS rates (14.1%) compared with a cohort who did not
receive the intervention (8.5%) (Tavasoli et al., 2016). Email reminders were also found to be
effective for increasing cancer screening rates and were equivalent to mailed reminders
(Chaudhry et al., 2007; Muller et al., 2009). In addition, a quality improvement project found that
educational handouts combined with a patient engagement tool and health advocate, along with
improving staff processes, led to 87% of the women enrolled receiving CCS (Kiser & Butler,
2020). The relatively small percentage increase found in this EBP project could be due to
reluctance of participants to complete screening due to the COVID-19 pandemic, and in
particular, rising COVID-19 case numbers in Porter County during the phone call intervention.
Secondary Outcomes
CCS uptake was collected following each intervention so that the relative efficacy of
each additional intervention could be assessed. McNemar’s test was conducted, and it was
found that the increase following the second reminder email was significant compared with CCS
completions following the initial reminder email X2 (1, N = 475) = 25.04, p = .000. In addition, the
increase in CCS after the phone calls was significant compared with the CCS rate following the
two emails X2 (1, N = 475) = 36.03, p = .000. In the literature, it was also found that multiple
interventions were more effective than single ones. Chan and So (2015) reported that an
outreach worker intervention, which included a letter and education, increased CCS more than a
direct mail intervention. In addition, it was found that letters combined with follow-up phone calls
led to an increase in CCS (Rees et al., 2018). Thompson et al. (2016) reported that the highintensity group, who received a lay health worker providing education, reminder, and assistance
in scheduling an appointment, had a significant increase in CCS compared with the low-intensity
group receiving an educational video. Finally, Fernandez-Esquer et al. (2020) reported that
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participants who received the services of a peer navigator, including education, assistance with
scheduling, and reminders, had increased CCS uptake (83.8%) compared with participants who
only received educational sessions and brochures (50%); the increase was significant (X2 =
8.54, df = 1, p = .003).
For patients of all six clinics who only received the emails, CCS uptake was also
collected over five months. Patients of all six clinics received two emails and patients of the
clinic in Porter County who were not usual patients of that clinic’s PCPs also received a third
email. Within this group of participants, it was found that 313 out of 4,374 (7.15%) had
completed CCS. This proportion was lower than among the target group because it represented
all patients who had been seen at the clinic in the past year. Many of these patients had a PCP
who was not affiliated with the FQHC, and therefore, were not likely to complete their CCS at
the project site. Some patients may have seen the reminder and scheduled their CCS
elsewhere. Participants were sent an email even if they only had one encounter, including an
urgent care visit, within the past year before the project was implemented.
For the 391 total participants who completed CCS, results of the Pap and HPV tests
were collected via chart review. This review included patients of all six clinics of the FQHC, the
one in Porter County and the other five. It was found that 37 participants (9.4%) had abnormal
Pap test results, 30 (7.7%) had HPV detected, and 19 of these had both an abnormal Pap and
HPV detected. Of the abnormal Pap tests, only two were in the severely abnormal range and
likely to require treatment. The others were only slightly abnormal and likely only needed further
testing. For these participants, the abnormal cells were caught and could be monitored or
treated early, before they became cervical cancer, in most cases. In addition, 24 participants
had an infection discovered by the test, including Candida, Bacterial Vaginosis, Trichomonas,
Actinomyces, Herpes, or Fungal infection. Finding and treating these infections provided
another way to improve these women’s health.
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Strengths and Limitations of the DNP Project
Strengths
Strengths of this project included the large number of participants who were able to be
included in both the intervention and comparison groups (N = 1109). Since patients at the
project site opt-in to quality improvement type projects when they enroll with the FQHC, no
consents were needed. Therefore, all eligible patients of the facility could receive the
interventions and be included in the project. The large sample size allows for more confident
generalization of the results to a larger population. Also, the population health software utilized
by the project site was helpful in collecting information on the intervention and comparison
groups. This software allowed data on demographics and CCS completion status to be collected
more quickly and easily for the group, rather than needing to complete individual chart reviews
for each participant.
In addition, the support of staff members was important in this project’s success. The
Quality Improvement Coordinator was available to assist the project manager in utilizing the
population health software, sending the emails, and obtaining data on patient surveys. She and
the Information Technology staff provided a laptop for the project manager to use, including
troubleshooting when things were not working correctly, as well as setting up a phone line for
the phone call intervention. In addition, a Spanish-speaking case manager assisted with
translating the emails into Spanish and making phone calls to the Spanish-speaking patients.
The Quality Improvement Coordinator and Quality Improvement Director worked with the project
manager and appointment scheduling staff to identify an appropriate individual to whom calls
could be transferred for scheduling. Finally, the data analyst provided invaluable support in
pulling data on CCS completions periodically throughout the project.
Within the emails that were sent, having a link to online scheduling was a strength of the
intervention. The Quality Improvement Coordinator reported an increase in online selfscheduling during the days following the two emails being sent out. This could be another
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potential advantage over a mailed intervention, allowing for quicker and more convenient
scheduling of CCS compared with having to make a phone call during business hours.
An advantage of the phone call intervention was that it allowed discovery of 60
participants who had completed CCS with another provider outside the FQHC. The project
manager collaborated with the Quality Improvement Coordinator and provided the names of
these participants to her. Those participants’ medical records would then be requested from the
appropriate provider and their charts updated, increasing the overall rates for CCS among the
FQHC’s patient population, although these completions were not included in this project. In
addition, the finding that 16 participants had a previous hysterectomy was also forwarded to the
Quality Improvement Coordinator and could be verified and added to the patient’s medical
history, allowing them to be excluded from the population due for CCS. These findings helped
improve the clinic’s performance on the quality measure of CCS rates. Updating these patient
charts was an additional benefit of this EBP project, helping increase overall CCS rates among
the FQHC population. In addition, some participants stated they would schedule their CCS with
an outside provider. Therefore, the project had benefits for those women’s health, although the
outcomes were not measurable due to being with a different facility. By expanding the phone
call interventions to the other five clinics, the FQHC has the potential to further increase its CCS
rates in this way.
Limitations
Some limitations were encountered with regards to providing the interventions to
Spanish-speaking patients. Although the emails were sent in Spanish, the link to online
scheduling was not included in their emails. The link and the website that it went to were in
English. Therefore, it was decided that the link would not be included, and participants were
instead instructed to call for an appointment. The phone line would then have the option to
reach a Spanish-speaking appointment scheduler. Being able to provide a link and website with
some information in Spanish would have allowed this patient population to complete online self-
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scheduling, as well. In addition, since the project manager is not fluent in Spanish, the phone
call intervention was completed by a Spanish-speaking case manager, whereas the other phone
calls were all made by the project manager. This could have led to greater variability in the
intervention. However, a script in Spanish was provided to the case manager to promote
consistency.
Many limitations were encountered during this project due to the COVID-19 pandemic.
First, a reluctance to receive cancer screening has been reported during the pandemic, with an
86% to 94% decrease found between January and March 2020 in a recent study (Kiser &
Butler, 2020). During the phone call intervention, several participants stated they were not
willing to schedule CCS due to concerns about COVID-19. The project manager reassured
these participants that the FQHC had extra precautions in place to promote safety, educated
them on the importance of completing CCS in a timely manner, and encouraged them to call
back when they were ready to schedule their appointment.
In addition, the project site had safety protocols in place due to the pandemic which
restricted the project manager’s ability to collaborate with stakeholders. The project manager
was not permitted to present the project proposal directly to the board or to the clinic or
scheduling staff due to safety protocols to reduce contact between clinic staff and other staff of
the facility. Instead, a proposal was written by the project manager and presented to the board
by the Quality Improvement Director for their consideration and approval. In addition, a
PowerPoint presentation was prepared by the project manager, then distributed to the
healthcare providers and managers at their meeting by the Quality Improvement Director. An
email was written by the project manager and sent to the appointment scheduling staff by their
manager describing the project, giving dates when the emails would be sent and phone calls
made, and requesting their assistance. Periodically, emails were sent to the managers,
healthcare providers, and scheduling staff to update them on the preliminary outcomes and
progress of the project. The project manager provided her contact information but did not
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receive any comments or questions from the staff. Following completion of the project and
outcome evaluation, a voice-over PowerPoint was developed and sent to managers and PCPs
via email. Also, an email was sent to the scheduling staff summarizing the results, along with
the poster. In this way, appropriate information was provided to the clinic staff, but feedback and
collaboration was not facilitated as would have been possible with in-person meetings.
Additional challenges were encountered due to limited resources. Initiation of the phone
call intervention was delayed by a week due to difficulty in securing a phone and setting up a
phone line for this purpose. When the project site began administering COVID-19 vaccines,
laptops were needed for staff administering the vaccines and no laptop was available for the
project manager to use during the first week and a half. Fortunately, the timing was after
implementation was complete, so not having a laptop only delayed the data entry and analysis.
While conducting the phone call intervention, another limitation was that the project
manager did not reach most of the participants and instead left a voicemail. The facility did not
want a message left to return the call to that extension, since the project manager may not be
there the following day. So instead, a more general message was left instructing the participant
to call the facility’s main number to schedule their appointment. If the participants had been able
to return calls to the project manager, this would have allowed for a more personalized
intervention. Also, some of those participants may have been up-to-date on their CCS with an
outside provider, but this information was not able to be discovered without talking directly to
them. In addition, a few of the participants were not able to receive even a phone message, due
to their voicemail being full or not set up or the number out of service. The project manager
attempted these phone calls again at a later date and was able to reach some of them, but nine
participants were unable to be reached. Finally, the facility phone line was down a few times
during the phone call intervention, which delayed their completion and may have prohibited
participants from calling back to schedule appointments.
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Implications for the Future
Practice
The results of this project suggest that education and reminders are effective strategies
to increase CCS rates. Since this EBP project was conducted at only one clinic of the FQHC as
a pilot, it would be recommended to implement these interventions at all six sites in the future.
The Quality Improvement Coordinator who assisted with the project plans to send out the
education and reminder emails to patients of all six clinics in the future. However, the project
manager is not employed by the facility and would not be able to assist with phone calls in the
future. According to the Quality Improvement Director, the FQHC is now working with patient
care navigators, who are making phone calls to patients to encourage them to complete
screening tests. She stated that they are starting by calling those patients who already have a
test ordered but have not yet completed their screening. However, she stated that the patient
care navigators would be able to call all patients due for screening at all sites in the future, as
well as providing personalized care to address barriers and educate patients on the free
screenings available. Lay health navigators who provided education and reminders were found
to be effective to increase CCS in the literature (Dunn et al., 2017; Rees et al., 2018). In
addition, Plourde et al. (2016) and Duffy et al. (2017) reported that patients who received a
recommendation for CCS from their healthcare provider were more likely to complete it than
those who did not. Therefore, another recommendation would be for healthcare providers to
remind and encourage their patients to complete CCS.
EBP Model
Utilizing the six steps within the Larrabee Model for Change to Evidence-Based Practice
was a positive framework to guide this change. The EBP Model gave the project manager, who
was new to the project site and to EBP implementation, a detailed roadmap to follow. During the
initial step, assessing the need for change in practice, identifying the problem, including
stakeholders such as quality improvement staff and the medical director, collecting data on
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current practices, and comparing internal with external data for CCS rates helped to define the
problem (Rosswurm & Larrabee, 1999). Following this process helped support the need for
change in practice. In step two, linking problem interventions and outcomes, the outcome
indicator of CCS completion was identified and possible interventions, including education and
reminders, were considered.
While following step three of the Larrabee Model, synthesizing best evidence, a
comprehensive literature search was conducted, best evidence was critiqued and synthesized,
and the results were compared with what was feasible within the project site, as well as benefits
and risks to participants (Rosswurm & Larrabee, 1999). In step four, designing the practice
change, it was determined that sending out mass text notifications was not possible, so an
alternative plan of sending a second email was developed. For step five, this project was
implemented as a pilot study at one clinic, as suggested by the model, and the increased CCS
rates provide strong support for a change in practice at the other five clinics of the FQHC.
Finally, step six involves integrating and maintaining the change in practice. The project
manager was able to meet with the Quality Improvement Director and Quality Improvement
Coordinator and found that implementing the phone call and email interventions at all six clinics
is planned in the future. In this way, the project manager promoted sustainability of the
interventions in the future.
Research
The results of this project were certainly affected by its being conducted during a
pandemic. Recommendations for future research would include carrying out similar projects or
research in the future when there would be fewer challenges and restrictions due to the
pandemic. In addition, several pieces of literature found provided strong support for the use of
lay health navigators or outreach workers to increase CCS, especially for women of minority
race or ethnicity (Braun et al., 2015; Chan & So, 2015; Dunn et al., 2017; Rees et al., 2018;
Thompson et al., 2016). Training and utilizing lay health navigators were beyond the time frame,
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budget and scope of this EBP project. However, future research could focus on the use of lay
health navigators within the FQHC population.
Education
Patient education is needed, especially in the underserved population of this FQHC with
its low CCS rates. The education is necessary to inform participants about why CCS is needed,
what is involved with Pap and HPV testing, and the benefits of early detection of cervical
cancer. The outcomes of this project supported providing educational materials as an effective
intervention to increase CCS rates. In addition, much of the literature supported in-person
individual and group education to improve CCS uptake (Chan & So, 2015; Duffy et al., 2017;
Saei Ghare Naz, 2018). Continuing patient education about CCS through emails and phone
calls, as well as in-person education, would be recommended.
Conclusion
The primary outcome of this project determined that an educational email, combined
with a reminder email and phone call intervention, significantly increased CCS uptake when
compared with the usual practice of sending a single email. Examining the secondary outcome
found that the second email and phone calls each were significantly more effective than the
previous interventions alone. The phone call interventions were conducted only at one clinic of
the FQHC, as a pilot. Due to the success of this project, it is recommended to implement the
interventions at all six clinics of the FQHC on an annual basis in the future. In addition, these
interventions should be implemented in other primary care clinics to increase CCS rates.
By finding abnormal results on Pap and HPV tests, several of the women who completed
CCS could be treated early or monitored more frequently, enabling prevention and less invasive
treatment. In this way, morbidity and mortality could be decreased. This EBP project met its
goals of improving CCS rates and reducing eventual cases of cervical cancer which develop in
the at-risk population of an FQHC. Education and reminders were provided to encourage
women to make their health a priority.
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reminder (n =
457), or usual
care (n =
494).

Systematic
Review

13 studies,
including 5
crosssectional
studies about
Pap test
uptake.

Systematic
review

16 studies,
RCTs and
quasi-RCTs

62
intervention:
email reminder
sent through
secure system;
Letter
intervention: sent
letter with
identical content
to email.
DV: Completion
of CRC screening
within 3 months.
Contextual factors
associated with
increased Pap
test uptake:
female providers,
facilities with QI
program, PCP
notified of
specialty visits,
areas with more
access to a car.

significant (p < 0.0005). Email
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Ghasemi, V., &
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Kone Pefoyo, A. J.,
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Kupets, R. (2016).
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Preventive
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IV: Control group,
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statistically significant
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increase CCS, and healthcare
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Receiving mailed letter
increased Pap test uptake
(AOR = 1.74).
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Thompson, B.,
Carosse, E. A.,
Jhingan, E., Wang,
L., Holte, S. E.,
Byrd, T. L.,
Benavides, M. C.,
Lopez, C., MartinezGutierrez, J., Ibarra,
G., Gonzalez, V. J.,
Gonzalez, N. E., &
Duggan, C. R.
(2016). Results of a
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increase cervical
cancer screening
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Cancer, 123, 666674. DOI:
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To compare
the
effectiveness
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intervention
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and control
group on
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Controlled Trial
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women at an
FQHC in
Washington
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IV: Control group,
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intervention:
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Spanish-language
video mailed to
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education session
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Significantly higher Pap testing Level
in high-intensity arm (53.4%)
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than control arm (34%; p ‹
High
0.001) or low-intensity (38.7%;
p ‹ 0.01). No statistically
significant difference between
low-intensity and control (p =
0.40).
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Appendix B

Cervical Cancer Screening Education Email

It is time to schedule your Pap test!
Dear (Patient Name),
Our records show that you are past due for a Pap appointment.
Women ages 21 to 30 in most cases need a Pap test every three years, while women ages
31 to 64 usually need a Pap every five years. Getting timely Pap exams is a vital way to
protect your health.
Cervical cancer can develop with no initial symptoms. A Pap exam can find changes in
your cervix cells before they turn into cancer. Early detection of precancerous or cancerous
cells can lead to less invasive procedures and treatments. A Pap test is a quick and simple
procedure to detect cervical cancer.
To find out more about Pap and HPV testing, click here Fact Sheet.
You can get a Pap test from one of our gynecologists or family practice providers at
███████ Health Centers. Make your health a priority by scheduling an appointment with
your healthcare provider.
Book a Pap appointment today. Call us at (219) 763-8112 or schedule your appointment
online below.

Sincerely,

███████ Health Centers
█
███████ Health Centers is taking the COVID-19 Pandemic very seriously. During these
challenging times, we assure you that we are staying true to our mission and will continue
to care for our community. There may be some visible changes as we have made
adjustments to our registration procedures. We are working very hard to keep all patients,
employees, and visitors safe.

Unsubscribe from this list
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Appendix C
Educational Fact Sheet

A FACT SHEET FROM THE OFFICE ON WOMEN’S HEALTH

Pap and HPV tests
Pap tests (or Pap smears) look for cancers and
precancers in the cervix. Precancers are cell changes
that can be caused by the human papillomavirus
(HPV). HPV is a sexually transmitted infection that
goes away on its own in most people. If it does not go
away, HPV can lead to cervical cancer. An HPV test
looks for HPV in cervical cells.

Q: Why do I need Pap and HPV tests?
A: A Pap test can save your life. It can find
cervical cancer cells early. The chance of successful
treatment of cervical cancer is very high if the
disease is caught early.
An HPV test can give your doctor more information
about the cells from your cervix. For example, if
the Pap test shows abnormal cervical cells, the HPV
test can show whether you have a type of HPV that
causes cervical cancer.

Q: Who should get regular Pap or HPV tests?
A: Most women 21 to 65 years old should get Pap
tests as part of routine health care. Even if you are
not currently sexually active, got the HPV vaccine, or
have gone through menopause, you still need regular
Pap tests. Experts recommend:
• Women 21–29 get a Pap test every 3 years
• Women 30–65 get:

◦
◦
◦

A Pap test every 3 years, or
An HPV test every 5 years, or
A Pap and HPV test together (called co-testing)
every 5 years

www.womenshealth.gov | 1-800-994-9662

Women older than 65 need a Pap test if they have never
been tested or if they have not been tested after age 60.
Some women may need Pap or HPV testing more often.

Q: How do I prepare for a Pap or HPV test?
A: You do not have to do anything special to
prepare for a Pap or HPV test. Also, you should not
douche before a Pap or HPV test. Most doctors do
not recommend douching for any reason. You also
should not put anything in or around your vagina to
clean it, other than soap and water on the outside of
your vagina.

Q: Are Pap and HPV tests painful?
A: Some women find Pap and HPV tests
uncomfortable, but the tests should not be painful.
You will feel pressure as your doctor or nurse puts
the speculum (a tool that helps your doctor or nurse
see your cervix) into your vagina.
If you have never had sexual intercourse or if you
have had pain when something is put into your
vagina, you can ask your doctor or nurse to use a
smaller speculum.
You can also help lessen or prevent pain by urinating
before the test to empty your bladder or by taking
an over-the-counter pain reliever, such as aspirin,
acetaminophen, or ibuprofen, about an hour before
your Pap or HPV test.
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Pap and HPV tests

Q: What do my Pap test results mean?
A: Your Pap test results will say one of these
three things:

• Normal. The cells collected from your cervix
during the Pap test look like they should and
you do not have to do anything until your next
Pap test.
• Unclear. Your doctor does not know whether the
cells collected from your cervix are normal or
abnormal. Your doctor may do more testing right
away to rule out any problems, or your doctor
may have you come back in 6 months or a year
for another Pap test.

• Abnormal. The cells collected from your cervix
during your Pap test look abnormal. Abnormal
Pap test results do not mean you have cancer,
so your doctor must do other tests to find out
what should happen next. Your doctor may do
another Pap test right away or, if the cell changes
are minor, wait 6 months or a year before doing
another Pap test.

Q: Can a Pap test tell me whether I have
a sexually transmitted infection (STI)?

A: No. A Pap test is not used to find STIs. You must
ask your doctor to test you for STIs if you want to
have STI testing.

For more information…
For more information about Pap and HPV tests, call the OWH Helpline at 1-800-994-9662
or contact the following organizations:
National Breast and Cervical Cancer Early
Detection Program, CDC, HHS
1-800-232-4636 • www.cdc.gov/cancer/nbccedp
National Cancer Institute (NCI), NIH, HHS
1-800-422-6237 • www.cancer.gov

2

National Cervical Cancer Coalition
1-800-685-5531 • www.nccc-online.org
Planned Parenthood
1-800-230-7526 • www.plannedparenthood.org

American Cancer Society
1-800-227-2345 • www.cancer.org

A full fact sheet on this topic is available online at www.womenshealth.g ov . All material contained on this pag e is free of copyright restrictions
and may be copied, reproduced, or duplicated without permission of the Office on Women’s Health in the U.S. Department of Hea lth and
Human Services. Citation of the source is appreciated. OWH content is available for syndication throug h the HHS Syndication Storefront at
digitalmedia.hhs.gov.
Content last updated: September 20, 2018.

www.facebook.com/HHSOWH
www.twitter.com/WomensHealth

CERVICAL CANCER SCREENING

68
Appendix D

Cervical Cancer Screening Reminder Email

You are due for a Pap test!

Dear (Patient Name),
It is time to schedule your Pap test. Our records show that you are past due for this
appointment. This is a reminder to call us or go online to make your appointment today.
Put your health first!
If you are concerned about cost, know that ███████ provides free and low-cost screening tests
to those who qualify based on income.
To find out more about Pap and HPV testing, click here Fact Sheet.
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Book a Pap appointment today. Call us at (219) 763-8112 or click below to schedule online.

Sincerely,
███████ Health Centers

███████ Health Centers is taking the COVID-19 pandemic very seriously. During these
challenging times, we assure you that we are staying true to our mission and will continue to
care for our community. There may be some visible changes as we have made adjustments to
our registration procedures. We are working very hard to keep all patients, employees, and
visitors safe.
Unsubscribe from this list

DISCLAIMER:
Do not use this email address for communicating ANY clinical diagnostic or personal health information. This
email and any files transmitted with it are confidential and intended solely for the individual or entity to whom
they are addressed. If you are not the named addressee or legal authorized agent of the addressee you may not
disseminate, distribute, or copy this email. Please notify the sender immediately if you have received this
communication by mistake and delete this email and any files transmitted with it from your system. If you are
not the intended recipient, disclosing, copying, distributing or taking any action in reliance on the contents of this
information is strictly prohibited.
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Appendix E

Cervical Cancer Screening Third Email

Remember to schedule your Pap test!
Dear (Patient Name),
We noticed you have not yet scheduled your Pap test. According to our
records, you are past due for this appointment. This is a reminder to call us
or schedule your appointment online today. It is important to get screening
tests done on time to catch any abnormal cells early while they are typically
more treatable.
To find out more about Pap and HPV testing, click here Fact Sheet.
You can get a Pap test from one of our gynecologists or family practice
providers at ███████ Health Centers. We have appointments during
typical hours as well as evening and Saturday hours.
If you are concerned about cost, know that ███████ provides free and
low-cost screening tests to those who qualify based on income.
Book your Pap appointment today. Call us at (219) 763-8112 or click below
to schedule your appointment online.

Thank you for choosing ███████ for your healthcare needs. If you have
any questions or concerns about Pap or HPV testing, please contact your
healthcare provider.
Sincerely,
███████ Health Centers
███████ Health Centers is taking the COVID-19 Pandemic very seriously.
During these challenging times, we assure you that we are staying true to
our mission and will continue to care for our community. There may be
some visible changes as we have made adjustments to our registration
procedures. We are working very hard to keep all patients, employees, and
visitors safe.
Unsubscribe from this list
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Appendix F
Phone Call Script

Hello, this is Christiana McLean, a nurse practitioner student calling from ███████ Health Centers. I’m
calling today because our records show that you are due for a Pap test. It’s important to get this
screening test done on time to find any abnormal cells early, while they are typically more treatable. Can
I help you schedule that today?
We have appointments available during typical hours, as well as evening and Saturday hours. If you are
concerned about cost, know that ███████ provides free and low-cost screening tests to those who
qualify based on income.
Do you have any questions or concerns about getting the Pap test?
(If they agree to schedule, transfer to scheduling. If not, ensure they have number and encourage them
to call back to schedule.)
Thank you for your time and have a great day!

If leaving a message:
Hello, this is Christiana McLean, a nurse practitioner student calling from ███████ Health Center. This
message is for (Name). I am calling to follow up on the email you received about scheduling your
screening test. We have evening and Saturday appointments available as well as typical hours. If you are
concerned about cost, know that ███████ provides free and low-cost screening tests to those who
qualify based on income. Call us at 219-763-8112 to schedule your appointment.

